Dallas, TX -- (SBWIRE) -- 03/13/2014 -- RnRMarketResearch.com adds “Specialty Enzymes Market by Source (Microorganism, Plant, Animal), Type (Carbohydrases, Protease, Lipase, Polymerases & Nucleases), Application (Pharmaceutical, Research & biotechnology, Diagnostic, Bio-Catalyst) & Geography – Global Trends & Forecasts to 2018" report to its research database.
Specialty enzymes are natural proteins produced from micro organisms, plants and animals. An enzyme serves as catalysts for the chemical process that include the production of pharmaceuticals, diagnostics, research & biotechnology, and biocatalytic solutions. Enzymes increase reaction rates by decreasing the amount of energy required to form a complex of reactants that is competent to produce reaction products. Specialty enzymes according to their type are classified as carbohydrases, proteases, polymerases and nucleases, lipases, and others.
Specialty enzymes report covers analysis of the market structure by identifying various sub-segments of the global specialty enzymes market, Revenue forecasts of the global specialty enzymes markets and its various sub-markets/micro-markets with respect to four main regions- North America, Europe, Asia-Pacific, and Rest of the World (RoW). Major trends, drivers, and restraints of the global specialty enzymes market are identified and explained in detail.
Complete Report Available @ http://www.rnrmarketresearch.com/specialty-enzymes-market-by-source-microorganism-plant-animal-type-carbohydrases-protease-lipase-polymerases-nucleases-application-pharmaceutical-research-biotechnology-diagnostic-b-market-report.html .
The specialty enzyme markets include pharmaceutical, research and biotechnology, diagnostics and biocatalysts. Pharmaceutical manufacturers are witnessing increased awareness in incorporating biocatalysis into manufacturing processes. Enzymes are particularly useful to generate isomerically pure pharmaceuticals and fine chemicals In spite of numerous advantages of biocatalysis, manufacturers have been slow to adopt industrial-scale enzymatic approaches.
Specialty enzyme usage in the pharmaceutical industry is mainly for drug manufacture, disease diagnostics, or as therapy. Increasing implication of enzymes in therapies for diseases such as cancer, cardiovascular diseases, lysosomal storage disorders, pain and inflammation management, among others, is a tidal force that fuels market demand. Enzyme demand in the research and biotechnology end-market would benefit from the fall in DNA sequencing costs and the increase of new sequencing techniques. The vast majority of enzymes used in research and biotechnology, which spans over 80%of the demand, are devoted to DNA amplification and sequencing. This segment is led by DNA polymerases, which has experienced strong growth as new DNA sequencing techniques have been developed in recent years and the cost of DNA sequencing has dropped dramatically. The number of investigations is expected to increase, creating a strong business case for specialty enzymes
The North America is the largest market for specialty enzymes followed by Europe and Asia-Pacific respectively. Pharmaceuticals and diagnostics enzymes are expected to contribute more market share by 2018. Europe was the second largest market for the production and consumption of specialty enzymes.
The rising middle class population, increase in per capita income, rising healthcare expenditure, increasing prevalence of diseases, increasing affordability on the part of consumers, and rapid growth technologies find growing opportunities in Asia-Pacific and ROW. Countries such as China, India, South Africa, and Brazil have tremendous scope for the specialty enzyme market. The development of novel and superior performing products and rapid growing technology would enable specialty enzyme manufacturers to explore vast untapped potential of the emerging markets in Asia-Pacific and Latin American regions.
Buy a report copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=156143 .
Major points from table of contents
7 Specialty Enzyme Market, By Application
7.2.1 Enzyme Replacement Therapy
7.2.2 Thrombolytic Enzymes
7.2.3 Digestive Enzymes
7.3 Research & Biotechnology
8 Specialty Enzymes Market, By Geography
8.2 North America: Specialty Enzymes Market
8.2.1 U.S.: Specialty Enzyme Market
8.2.2 Canada: Specialty Enzyme Market
8.2.3 Mexico: Specialty Enzyme Market
8.3 Europe: Specialty Enzyme Market
8.3.1 Germany: Specialty Enzymes Market
8.3.2 U.K.: Specialty Enzymes Market
8.3.3 France: Specialty Enzyme Market
8.4 Asia Pacific: Specialty Enzyme Market
8.4.1 China:Specialty Enzyme Market
8.4.2 India:Specialty Enzyme Market
8.4.3 Japan:Specialty Enzyme Market
8.5 ROW : Specialty Enzymes Market
8.5.1 South Africa: Specialty Enzymes Market
9 Competitive Landscape
9.2 Agreements, Collaborations, & Partnerships: Most Preferred Strategic Approach
9.2.1 Maximum Developments in 2012
9.2.2 Sanofi & Life Technologies -The Most Active Players
9.4 New Products Launch & Product Developments
9.5 Agreements, Partnerships, & Collaborations
9.6 Expansions & Other Developments
10 Company Profiles
10.2 Amano Enzyme Inc.
10.3 Codexis Inc.
10.4 Sanofi S.A.
10.5 Roche Holding Ag.
10.6 Advanced Enzyme Technology Ltd.
10.7 Life Technologies
10.8 Nagase & Co. Ltd.
10.9 BBI Enzymes Ltd.
10.10 Affymetrix Inc.
Browse more reports on Enzyme Market @ http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology/enzyme .
Google Plus: https://plus.google.com/u/0/104156468549256253075/posts